These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 7680746)

  • 1. In vitro high resolution 1H-spectroscopy of the human prostate: benign prostatic hyperplasia, normal peripheral zone and adenocarcinoma.
    Schiebler ML; Miyamoto KK; White M; Maygarden SJ; Mohler JL
    Magn Reson Med; 1993 Mar; 29(3):285-91. PubMed ID: 7680746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy.
    Kurhanewicz J; Vigneron DB; Nelson SJ; Hricak H; MacDonald JM; Konety B; Narayan P
    Urology; 1995 Mar; 45(3):459-66. PubMed ID: 7533458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro proton spectroscopy of normal and abnormal prostate.
    Yacoe ME; Sommer G; Peehl D
    Magn Reson Med; 1991 Jun; 19(2):429-38. PubMed ID: 1715505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of human prostate cancer from benign hypertrophy by in vitro 1H NMR.
    Fowler AH; Pappas AA; Holder JC; Finkbeiner AE; Dalrymple GV; Mullins MS; Sprigg JR; Komoroski RA
    Magn Reson Med; 1992 May; 25(1):140-7. PubMed ID: 1375702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution.
    Kurhanewicz J; Vigneron DB; Hricak H; Narayan P; Carroll P; Nelson SJ
    Radiology; 1996 Mar; 198(3):795-805. PubMed ID: 8628874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of human prostate cancer, benign prostatic hyperplasia and normal prostate by in vitro 1H and 31P magnetic resonance spectroscopy.
    Cornel EB; Smits GA; Oosterhof GO; Karthaus HF; Deburyne FM; Schalken JA; Heerschap A
    J Urol; 1993 Dec; 150(6):2019-24. PubMed ID: 7693985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo differential diagnosis of prostate cancer and benign prostatic hyperplasia: localized proton magnetic resonance spectroscopy using external-body surface coil.
    Kim JK; Kim DY; Lee YH; Sung NK; Chung DS; Kim OD; Kim KB
    Magn Reson Imaging; 1998 Dec; 16(10):1281-8. PubMed ID: 9858286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citrate alterations in primary and metastatic human prostatic adenocarcinomas: 1H magnetic resonance spectroscopy and biochemical study.
    Kurhanewicz J; Dahiya R; Macdonald JM; Chang LH; James TL; Narayan P
    Magn Reson Med; 1993 Feb; 29(2):149-57. PubMed ID: 8429778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
    Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C
    Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic characterization of the infiltrating immune cells in normal prostate, benign nodular prostatic hyperplasia and prostatic adenocarcinoma.
    Hussein MR; Al-Assiri M; Musalam AO
    Exp Mol Pathol; 2009 Apr; 86(2):108-13. PubMed ID: 19111537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo proton magnetic resonance spectroscopy of diseased prostate: spectroscopic features of malignant versus benign pathology.
    García-Segura JM; Sánchez-Chapado M; Ibarburen C; Viaño J; Angulo JC; González J; Rodríguez-Vallejo JM
    Magn Reson Imaging; 1999 Jun; 17(5):755-65. PubMed ID: 10372529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metachromasia in the human prostate: a histochemical difference between benign prostatic hyperplasia and prostatic carcinoma.
    Arcadi JA
    J Urol; 1988 Feb; 139(2):315-7. PubMed ID: 2448498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton MR T2 maps correlate with the citrate concentration in the prostate.
    Liney GP; Lowry M; Turnbull LW; Manton DJ; Knowles AJ; Blackband SJ; Horsman A
    NMR Biomed; 1996 Apr; 9(2):59-64. PubMed ID: 8887369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo quantification of citrate concentration and water T2 relaxation time of the pathologic prostate gland using 1H MRS and MRI.
    Liney GP; Turnbull LW; Lowry M; Turnbull LS; Knowles AJ; Horsman A
    Magn Reson Imaging; 1997; 15(10):1177-86. PubMed ID: 9408138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo proton MR spectroscopy reveals altered metabolite content in malignant prostate tissue.
    Heerschap A; Jager GJ; van der Graaf M; Barentsz JO; de la Rosette JJ; Oosterhof GO; Ruijter ET; Ruijs SH
    Anticancer Res; 1997; 17(3A):1455-60. PubMed ID: 9179183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathologic characterization of human prostate tissue with proton MR spectroscopy.
    Swindle P; McCredie S; Russell P; Himmelreich U; Khadra M; Lean C; Mountford C
    Radiology; 2003 Jul; 228(1):144-51. PubMed ID: 12832578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander?
    Shah R; Mucci NR; Amin A; Macoska JA; Rubin MA
    Am J Pathol; 2001 May; 158(5):1767-73. PubMed ID: 11337374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of prostate cancer, benign prostatic hyperplasia and normal prostates using transrectal 31phosphorus magnetic resonance spectroscopy: a preliminary report.
    Narayan P; Jajodia P; Kurhanewicz J; Thomas A; MacDonald J; Hubesch B; Hedgcock M; Anderson CM; James TL; Tanagho EA
    J Urol; 1991 Jul; 146(1):66-74. PubMed ID: 1711587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioenergetic theory of prostate malignancy.
    Costello LC; Franklin RB
    Prostate; 1994 Sep; 25(3):162-6. PubMed ID: 7520580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostatic intraepithelial neoplasia: a lesion that may be confused with cancer on prostatic ultrasound.
    Brawer MK; Rennels MA; Nagle RB; Soiderer MH; Lee F
    J Urol; 1989 Dec; 142(6):1510-2. PubMed ID: 2479777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.